Skip to content

The role of PMILAGH model in the diagnosis of invasive lung adenocarcinoma with ground vitreous nodules

The role of PMILAGH model in the diagnosis of invasive lung adenocarcinoma with ground vitreous nodules

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036841
Enrollment
Unknown
Registered
2020-08-25
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Case series:none

Sponsors

Shanghai Chest Hospital, Shanghai Jiao Tong University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Ground-glass lung nodules (GGN) were observed on HRCT; 2) AAH, AIS, MIA or IAC were diagnosed by referring to the new standard pathological diagnosis of lung adenocarcinoma by the World Health Organization (WHO) in 2015 [5]; 3) HRCT and surgical interval < 1 month; 4) HRCT records include: GGN position, GGN distance from pleura, GGN diameter, GGN area, CT value, density uniformity, shape, edge, whether there is burr, pleural depression, whether there is aeration of bronchi, whether there is vacuolar sign, vascular change, whether the edge of lung and tubercle is clear, whether there is lobulation

Exclusion criteria

Exclusion criteria: 1) Motion artifacts under HRCT and impact assessment; 2) Diffuse lesions appeared near GGN

Design outcomes

Primary

MeasureTime frame
HRCT;

Countries

China

Contacts

Public ContactLi Rong

Clinical Research Center of Shanghai Chest Hospital

lwro@hotmail.com+86 18017321327

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026